Integrative transcriptome analysis reveals dysregulation of canonical cancer molecular pathways in placenta leading to preeclampsia

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Moslehi, Roxana ^a,b   Mills, James L ^c   Signore, Caroline ^c   Kumar, Anil ^a   Ambroggio, Xavier ^d   Dzutsev, Amiran ^e,f  

^a UNT Health Sciences Center   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e SAIC FREDERICK INC   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTOME; TUMOR PROTEIN;

ADULT; ARTICLE; FEMALE; GENE EXPRESSION REGULATION; HUMAN; META ANALYSIS; METABOLISM; MIDDLE AGED; PLACENTA; PRECANCER; PREECLAMPSIA; PREGNANCY; YOUNG ADULT;

ADULT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM PROTEINS; PLACENTA; PRE-ECLAMPSIA; PRECANCEROUS CONDITIONS; PREGNANCY; TRANSCRIPTION FACTORS; TRANSCRIPTOME; YOUNG ADULT;

EID: 84884146971     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02407     Document Type: Article

References (52)

1. Moslehi, R. et al. Adverse effects of trichothiodystrophy DNA repair and transcription gene disorder on human fetal development. Clin Genet 77, 365-73 (2010).
2. Lehmann, A. R. DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie 85, 1101-11 (2003).
3. Tamura, D. et al. High-risk pregnancy and neonatal complications in the DNA repair and transcription disorder trichothiodystrophy: report of 27 affected pregnancies. Prenat Diagn 31, 1046-53 (2011).
4. Itin, P. H., Sarasin, A. & Pittelkow, M. R. Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J Am Acad Dermatol 44, 891-920; quiz 921-4 (2001).
5. Nikolov, D. B. & Burley, S. K. RNA polymerase II transcription initiation: a structural view. Proc Natl Acad Sci USA 94, 15-22 (1997).
6. Zurita, M. & Merino, C. The transcriptional complexity of the TFIIH complex. Trends Genet 19, 578-84 (2003).
7. Fuss, J. O. & Tainer, J. A. XPB and XPD helicases in TFIIH orchestrate DNA duplex opening and damage verification to coordinate repair with transcription and cell cycle via CAK kinase. DNA Repair (Amst) 10, 697-713 (2011).
8. Moslehi, R. et al. Phenotype-specific adverse effects of XPD mutations on human prenatal development implicate impairment of TFIIH-mediated functions in placenta. Eur J Hum Genet 20, 626-31 (2012).
9. Uzan, J., Carbonnel, M., Piconne, O., Asmar, R. & Ayoubi, J. M. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag 7, 467-74 (2011).
10. Ciantar, E. & Walker, J. J. Pre-eclampsia, severe pre-eclampsia and hemolysis, elevated liver enzymes and low platelets syndrome: what is new? Womens Health (Lond Engl) 7, 555-69 (2011).
11. Johnson, M. P. et al. The ERAP2 gene is associated with preeclampsia in Australian and Norwegian populations. Hum Genet 126, 655-66 (2009).
12. Johansson, A. et al. Identification of ACOX2 as a shared genetic risk factor for preeclampsia and cardiovascular disease. Eur J Hum Genet 19, 796-800 (2011).
13. Moses, E. K. et al. A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. Am J Hum Genet 67, 1581-5 (2000).
14. Johnson, M. P. et al. Genome-Wide Association Scan Identifies a Risk Locus for Preeclampsia on 2q14, Near the Inhibin, Beta B Gene. PLoS One 7, e33666 (2012).
15. Roten, L. T. et al. A low COMT activity haplotype is associated with recurrent preeclampsia in a Norwegian population cohort (HUNT2). Mol Hum Reprod 17, 439-46 (2011).
16. Roten, L. T. et al. Association between the candidate susceptibility gene ACVR2A on chromosome 2q22 and pre-eclampsia in a large Norwegian population-based study (the HUNT study). Eur J Hum Genet 17, 250-7 (2009).
17. Fenstad, M. H. et al.Genetic and molecular functional characterization of variants within TNFSF13B, a positional candidate preeclampsia susceptibility gene on 13q. PLoS One 5 (2010).
18. Rhodes, D. R. & Chinnaiyan, A. M. Integrative analysis of the cancer transcriptome. Nat Genet 37 Suppl, S31-7 (2005).
19. Sitras, V. et al. Differential placental gene expression in severe preeclampsia. Placenta 30, 424-33 (2009).
20. Winn, V. D. et al. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology 150, 452-62 (2009).
21. Nishizawa, H. et al. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta 28, 487-97 (2007).
22. Nishizawa, H. et al. Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction. Reprod Biol Endocrinol 9, 107 (2011).
23. Allocco, D. J., Kohane, I. S. & Butte, A. J. Quantifying the relationship between coexpression, co-regulation and gene function. BMC Bioinformatics 5, 18 (2004).
24. Su, A. I. et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101, 6062-7 (2004).
25. Winn, V. D. et al. Gene expression profiling of the human maternal-fetal interface reveals dramatic changes between midgestation and term. Endocrinology 148, 1059-79 (2007).
26. Hong, J. S. et al. A Comparative Analysis of the Transcriptome of Hypoxia and Inflammation in Swan 71 Human Trophoblast Cells: Its Implications in Preeclampsia. http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc5GSE31679 (2012).
27. Tang, Q.e.a. Endothelial cell response to hypoxia and subsequent reoxygenation. http://www.ncbi.nlm.nih.gov/sites/GDSbrowser?acc5GDS1968 (2004).
28. Offman, J. et al. Transcriptional changes in trichothiodystrophy cells. DNA Repair (Amst) 7, 1364-71 (2008).
29. Uhlen, M. et al. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 28, 1248-50 (2010).
30. Bansal, A.e.a. RNA-seq analysis of K562 cells (K562-shX) with stable integration of a tet-inducible shRNA targeting a candidate (X) transcription factor from ENCODE/HudsonAlpha-MyersLab. http://www.ncbi.nlm.nih.gov/geo/query/ acc.cgi?acc5GSE33816 (2012).
31. Garber, M. et al. A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol Cell 47, 810-22 (2012).
32. Dudley, J. T. & Butte, A. J. Identification of discriminating biomarkers for human disease using integrative network biology. Pac Symp Biocomput 27-38 (2009).
33. Julian, C. G. High altitude during pregnancy. Clin Chest Med 32, 21-31, vii.
34. Hung, T. H.& Burton, G. J. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 45, 189-200 (2006).
35. Okamoto, A., Iwamoto, Y. & Maru, Y. Oxidative stress-responsive transcription factor ATF3 potentially mediates diabetic angiopathy. Mol Cell Biol 26, 1087-97 (2006).
36. Han, W. & Lo, H. W. Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations. Cancer Lett 318, 124-34.
37. Hai, T., Wolfgang, C. D., Marsee, D. K., Allen, A. E. & Sivaprasad, U. ATF3 and stress responses. Gene Expr 7, 321-35 (1999).
38. Hoetzenecker, W. et al. ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression. Nat Med 18, 128-34.
39. Levy, R., Smith, S. D., Chandler, K., Sadovsky, Y. & Nelson, D. M. Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor. Am J Physiol Cell Physiol 278, C982-8 (2000).
40. Chen, S. C., Liu, Y. C., Shyu, K. G.&Wang, D. L. Acute hypoxia to endothelial cells induces activating transcription factor 3 (ATF3) expression that is mediated via nitric oxide. Atherosclerosis 201, 281-8 (2008).
41. Moll, S. J., Jones, C. J., Crocker, I. P., Baker, P. N. & Heazell, A. E. Epidermal growth factor rescues trophoblast apoptosis induced by reactive oxygen species. Apoptosis 12, 1611-22 (2007).
42. Thompson, M. R., Xu, D. & Williams, B. R. ATF3 transcription factor and its emerging roles in immunity and cancer. J Mol Med (Berl) 87, 1053-60 (2009).
43. Tejera, E., Bernardes, J. & Rebelo, I. Preeclampsia: a bioinformatics approach through protein-protein interaction networks analysis. BMC Syst Biol 6, 97 (2012).
44. Ferretti, C., Bruni, L., Dangles-Marie, V., Pecking, A. P. & Bellet, D. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum Reprod Update 13, 121-41 (2007).
45. Dackor, J., Caron, K. M. & Threadgill, D. W. Placental and embryonic growth restriction in mice with reduced function epidermal growth factor receptor alleles. Genetics 183, 207-18 (2009).
46. Juven-Gershon, T. & Kadonaga, J. T. Regulation of gene expression via the core promoter and the basal transcriptional machinery. Dev Biol 339, 225-9 (2010).
47. Collin de L'hortet, A., Gilgenkrantz, H. & Guidotti, J. E. EGFR: AMaster Piece in G1/S Phase Transition of Liver Regeneration. Int J Hepatol 2012 (2012).
48. Rocca-Serra, P. et al. ArrayExpress: a public database of gene expression data at EBI. C R Biol 326, 1075-8 (2003).
49. Schroeder, B. M. ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Am Fam Physician 66, 330-1 (2002).
50. Reiner, A., Yekutieli, D. & Benjamini, Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19, 368-75 (2003).
51. Eisenhart, C. The assumptions underlying the analysis of variance. Biometrics 3, 1-21 (1947).
52. Bader, G. D. & Hogue, C. W. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 4, 2 (2003). Development